Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published January 15, 2016 | Supplemental Material + Accepted Version
Journal Article Open

AMP-activated protein kinase mediates mitochondrial fission in response to energy stress

Abstract

Mitochondria undergo fragmentation in response to electron transport chain (ETC) poisons and mitochondrial DNA–linked disease mutations, yet how these stimuli mechanistically connect to the mitochondrial fission and fusion machinery is poorly understood. We found that the energy-sensing adenosine monophosphate (AMP)–activated protein kinase (AMPK) is genetically required for cells to undergo rapid mitochondrial fragmentation after treatment with ETC inhibitors. Moreover, direct pharmacological activation of AMPK was sufficient to rapidly promote mitochondrial fragmentation even in the absence of mitochondrial stress. A screen for substrates of AMPK identified mitochondrial fission factor (MFF), a mitochondrial outer-membrane receptor for DRP1, the cytoplasmic guanosine triphosphatase that catalyzes mitochondrial fission. Nonphosphorylatable and phosphomimetic alleles of the AMPK sites in MFF revealed that it is a key effector of AMPK-mediated mitochondrial fission.

Additional Information

© 2016 American Association for the Advancement of Science. Received 28 April 2015; accepted 9 December 2015. This research was supported by NIH grants R01DK080425, R01CA172229, and P01 CA120964 to R.J.S; R01GM062967 and R01GM110039 to D.C.C; R01NS089456 to F.P.; and K99NS091526 to T.L.L. Work in the laboratory of R.J.S. was also supported in part by the Leona M. and Harry B. Helmsley Charitable Trust (grant 2012-PG-MED002). E.Q.T. and N.P.Y. were supported by American Cancer Society fellowships (122123-PF-12-029-01-TBE and 123016-PF-PF-12-191-01-TBE, respectively). S.H. was supported by a European Molecular Biology Organization (EMBO) Long Term Fellowship (ALTF 1101-2013). K.H. was funded by a George E. Hewitt Foundation for Medical Research fellowship. O.C.L. was supported by an American Physiological Society William Townsend Porter predoctoral fellowship. R.J.S. is the William R. Brody Chair at the Salk Institute and a Howard Hughes Medical Institute Early Career Scientist. We thank A. Singh and G. Kasof at Cell Signaling Technology for developing the antibody to MFF P-Ser172 in conjunction with E.Q.T. and R.J.S. We thank the Waitt Biophotonics Core and Flow Cytometry Core at the Salk Institute for use of their instruments, which are supported by the Salk Institute (grant CCSG P30 CA014195). We thank C. Merkwirth and M. Adams for helpful discussions and M. Chun for critical reading of the manuscript.

Attached Files

Accepted Version - nihms-778814.pdf

Supplemental Material - aab4138-Toyama-SM-movie-S1.mov

Supplemental Material - aab4138-Toyama-SM-movie-S2.mov

Supplemental Material - aab4138-Toyama-SM-movie-S3.mov

Supplemental Material - aab4138-Toyama-SM-movie-S4.mov

Supplemental Material - aab4138-Toyama-SM-movie-S5.mov

Supplemental Material - aab4138-Toyama-SM.pdf

Files

aab4138-Toyama-SM.pdf
Files (35.8 MB)
Name Size Download all
md5:4ca3f4573703d7bd9cb7d37145a0bc0d
1.9 MB Download
md5:cf8d4468ed5a671e61bfd94deec3c752
2.9 MB Download
md5:e4188eb98405884453d790943dc7f365
2.3 MB Download
md5:c5bbc0e0de7c49a906f92caeaed1f237
2.7 MB Download
md5:a340e9944d4c5a9cc594fa6c2d348a9c
22.2 MB Preview Download
md5:9ede0bc05ee64441925fcca102f37c8a
931.4 kB Preview Download
md5:3ff7a3c58ef58dbf99b5de8807b711ed
2.8 MB Download

Additional details

Created:
August 20, 2023
Modified:
October 17, 2023